Vera Therapeutics Inc Strategic Asset Allocation Index

Latest as of September 2023: 0.0%

Vera Therapeutics Inc strategic asset allocation index. Vera Therapeutics Inc (VERA) has a Strategic Asset Allocation Index of 0.0% as of September 2023. Strategic assets (PP&E of $- plus long-term investments of $13.00K) total $13.00K, measured against net assets of $123.71 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Vera Therapeutics Inc (VERA) balance sheet quality index to measure how much of total assets are equity-financed.

SAAI

0.0%
Strategic Assets / Net Assets

Strategic Assets

$13.00K
PP&E + LT Investments

PP&E

$-
USD

Net Assets

$123.71 Million
USD

Strategic Asset Allocation Index of Vera Therapeutics Inc (2021–2022)

Strategic asset allocation index of Vera Therapeutics Inc from 2021 to 2022. This chart shows how Vera Therapeutics Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2021 to 2022. As of September 2023, the index stands at 0.0%, representing strategic assets of $13.00K against net assets of $123.71 Million USD. Check Vera Therapeutics Inc tangible equity quality to evaluate the tangible quality of the company's equity base.

Vera Therapeutics Inc Strategic Asset Allocation Index by Year (2021–2022)

Vera Therapeutics Inc strategic asset allocation index by year from 2021 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Vera Therapeutics Inc from 2021 to 2022, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see VERA stock market capitalisation.

Year SAAI Strategic Assets (USD) PP&E LT Investments Net Assets Change (pp)
2022 0.1% $109.00K $51.00K $58.00K $76.91 Million ▼ -1.1 pp
2021 1.2% $867.00K $- $867.00K $69.59 Million —
pp = percentage points